https://it.marketscreener.com/quotazioni/azione/CARA-THERAPEUTICS-INC-15672075/attualita/La-FDA-approva-il-farmaco-di-Cara-per-il-prurito-grave-nei-pazienti-con-malattie-renali-36229389/?utm_source=telegram&utm_medium=social&utm_campaign=share